Optimizing drug prescribing in managed care populations: Improving clinical and economic outcomes

Disease Management and Health Outcomes

Volumn 12, Issue 3, 2004, Pages 147-167

  Czubak, Rachel ^a   Tucker, Jasmine ^a   Zarowitz, Barbara J ^a,b,c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b Omnicare Inc   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALEFACEPT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC AGENT; ANTITUSSIVE AGENT; CIMETIDINE; CLARITHROMYCIN; DECONGESTIVE AGENT; DOXYCYCLINE; DRUG; FAMOTIDINE; FIBRINOLYTIC AGENT; RANITIDINE;

ADVERTIZING; BRONCHITIS; CHRONIC BRONCHITIS; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; COST BENEFIT ANALYSIS; DRUG COST; DRUG INFORMATION; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HEART INFARCTION; HOSPITALIZATION; HUMAN; MANAGED CARE; MEDICAL EDUCATION; MEDICARE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PSORIASIS; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 3042587918     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200412030-00002     Document Type: Review

References (104)

1. Centers for Medicare and Medicaid Services. 2003 CMS statistics 8014623597: US Department of Health and Human Services [online]. Available from URL: http://www.cms.hhs.gov/researchers/pubs/03cmsstats.pdf [Accessed 2004 Jan 31]
2. Centers for Medicare and Medicaid Services. Healthcare spending reaches $1.6 trillion in 2002 [online]. Available from URL: http://www.cms.hhs. gov/media/ press/release.asp?.counter = 935〉 [Accessed 2003 Oct 14]
3. Mehrotra A, Bodenheimer T, Dudley RA. Employers' efforts to measure and improve hospital quality: determinants of success. Health Aff 2003 Mar/Apr; 22 (2): 60-71
4. Board on Health Care Services. Fostering rapid advances in healthcare: learning from system demonstrations. Washington, DC: The National Academies Press, 2002
5. Adams K, Corrigan JM, editors. Priority areas for national action: transforming health care quality. Washington, DC: National Academy Press, 2003
6. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999
7. Institute of Medicine. Crossing the quality chasm: a new health system for the twenty-first century. Washington, DC: National Academy Press, 2001
8. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990 Mar; 47 (3): 533-43
9. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001 Mar/Apr; 41 (2): 192-9
10. National Committee for Quality Assurance. The Health Plan Employer Data and Information Set (HEDIS®) [online]. Available from URL: http:// www.ncqa.org/Programs/HEDIS/index.htm [Accessed 2003 Oct 14]
11. National Business Coalition on Health. eValue 8 [online]. Available at: http:// www.nbch.org/documents/evalue8brochure.pdf [Accessed 2004 Mar 8]
12. Fairman KA. The effect of new and continuing prescription drug use on cost: a longitudinal analysis of chronic and seasonal utilization. Clin Ther 2000 May; 22 (5): 641-52
13. Beers MH, Baran RW, Frenia K. Drugs and the elderly: part 1. The problems facing managed care. Am J Manag Care 2000 Dec; 6 (12): 1313-20
14. Finkelstein JA, Lozano P, Farber HJ, et al. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med 2002 Jun; 156 (6): 562-7
15. Rautakorpi UM, Lumio J, Huovinen P, et al. Indication-based use of antimicrobials in Finnish primary health care: description of a method for data collection and results of its application. Scand J Prim Health Care 1999 Jun; 17 (2): 93-9
16. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000 Oct; 25 (5): 333-40
17. Gonzales R, Steiner JF, Lum A, et al. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999 Apr 28; 281 (16): 1512-9
18. Zarowitz BJ, Stebelsky L, Gillanders F, et al. Improving medication safety through the reduction of polypharmacy in a large capitated population [abstract]. Pharmacotherapy 2003; 23: 1349
19. Andrade SE, Gurwitz JH, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists. Med Care 1999 Apr; 37 (4): 424-30
20. Brufsky JW, Ross-Degnan D, Calabrese D, et al. Shifting physician prescribing to a preferred histamine-2-receptor antagonist: effects of a multifactorial intervention in a mixed-model health maintenance organization. Med Care 1998 Mar; 36 (3): 321-32
21. Bloome M, Bronken T, Saier R, et al. Telehealth attainment of lipid goals through automated workflow technology [abstract]. Pharmacotherapy 2000 Oct; 20 (10): 1259
22. Smits H, Zarowitz B, Sahney VK, et al. The business case for pharmaceutical management: a case study. Field report #613. 2003 Apr. [online]. Available from URL: http://www.cmwf.org/programs/quality/ smits_pharmaceuticalmanagement_613.pdf [Accessed 2003 Oct 14]
23. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland: Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997 Aug 14; 337 (7): 441-6
24. Miller M, Byington R, Hunninghake D, et al. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada: prospective randomized evaluation of the vascular effects of Norvasc trial (PREVENT) investigators. Arch Intern Med 2000; 160 (3): 343-7
25. Levit K, Smith C, Cowan C, et al. Trends in US health care spending, 2001. Health Aff 2003 Jan/Feb; 22 (1): 154-64
26. National Institute for Health Care Management Research and Educational Foundation. Prescription drug expenditures in 2001: another year of escalating costs: 2002 May [online]. Available from URL: http://www.nihcm.org/spending2001. pdf [Accessed 2003 Oct 14]
27. US Department of Health and Human Services Administration on Aging. A profile of older Americans: 2002 [online]. Available from URL: http://www.aoa.gov/ prof/Statistics/statistics.asp [Accessed 2003 Mar 29]
28. Altman S, Parks-Thomas C. Controlling spending for prescription drugs. N Engl J Med 2002 Mar 14; 346 (11): 855-6
29. Calabretta N. Consumer-driven, patient-centered health care in the age of electronic information. J Med Libr Assoc 2002 Jan; 90 (1): 32-7
30. Hollander SM. Providing health information to the general public: a survey of current practices in academic health sciences libraries. Bull Med Libr Assoc 2000 Jan; 88 (1): 62-9
31. Angel JE. Advertising drugs. New York Times 2002 Jun 8; Sect. A: 14 (col. 4)
32. Rosenthal MB, Berndt ER. Promotion of prescription drugs to consumers. N Engl J Med 2002 Feb 14; 346 (7): 498-505
33. Mintzes B. Direct to consumer advertising is medicalising normal human experience. BMJ 2002 Apr 13; 347 (7342): 908-9
34. Mintzes B, Barer M. Influence of direct to consumer pharmaceutical advertising and patient's requests on prescribing decisions: two site cross sectional survey. BMJ 2002 Feb 2; 321: 278-9
35. Reichert S, Todd S, Halm E. Physicians' attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med 2000 Oct 9; 160 (18): 2799-803
36. Rochon P, Gurwitz J. Optimizing drug treatment for elderly people: the prescribing cascade. BMJ 1997 Oct 25; 315 (7115): 1096-9
37. Johnson J, Bootman L. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995 Oct 9; 155 (18): 1949-56
38. Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001; 8: 254-66
39. Senst BL, Achusism LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health-Syst Pharm 2001; 58 (12): 1126-32
40. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5
41. Zhan C, Sangl J, Bierman A, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 medical expenditure panel survey. JAMA 2001 Dec 12; 286 (22): 2823-9
42. Joyce GF, Escarce JJ, Solomon MD, et al. Employer drug benefit plans and spending on prescription drugs. JAMA 2002 Oct 9; 288 (14): 1733-9
43. Ernst M, Kelly M, Hoens J. Prescription medication costs: a study of physician familiarity. Arch Fam Med 2000 Nov-Dec; 9 (10): 1002-7
44. Giaquinta D, Lehman G, Miller R. A managed care stakeholder assessment of preventive medicine: practical applications, measurable results, evaluating success. J Manage Care Pharm 2002 Jul-Aug; 8 (4 Suppl.): 1-10
45. Groves K, Flanagan PS, MacKinnon N, et al. Why physicians start or stop prescribing a drug: literature review and formulary implications. Formulary 2002 Apr; 37: 186-94
46. Remington T. The pharmacist-prescriber interface. In: Mueller BA, Bertch KE, Zarowitz BJ, et al., editors. Pharmacotherapy self-assessment program. 4th ed. Kansas City (MO): American College of Clinical Pharmacy, 2001: 61-83
47. Butler C, Rollnick S, Statt N. The practitioner, the patient and resistance to change: recent ideas on compliance. CMAJ 1996 May 1; 154 (9): 1357-62
48. Majumdar SR, Soumerai SB. Why most interventions to improve physician prescribing do not seem to work. CMAJ 2003 Jul; 169 (1): 30-1
49. American Medical Association. Ethical opinions and guidelines. E-8.061 Gifts to physicians from industry [online]. Available from URL: http://www.ama-assn.org/ama/pub/print/article/4001-7922.html [Accessed 2003 Oct 14]
50. Pharmaceutical Researchers and Manufacturers of America. PhRMA Code on interactions with healthcare professionals [online]. Available from URL: http:// www.phrma.org/publications/policy//2002-04-19.391.pdf [Accessed 2003 Sep 7]
51. Bodenheimer T. Disease management in the American market. BMJ 2000 Feb 26; 320 (7234): 563-6
52. Navarro RP, Christensen D, Leider H. Disease management programs. In: Navarro RP, editor. Managed care pharmacy practice. Gaithersburg (MD): Aspen Publishers, 1999: 371-95
53. Bodenheimer T. Disease management: promises and pitfalls. N Engl J Med 1999 Apr 15; 340 (15): 1202-5
54. Hunter DJ, Fairfield G. Disease management. BMJ 1997 Jul 5; 315 (7099): 50-3
55. Harris JM. Disease management: new wine in new bottles? Ann Intern Med 1996 May 1; 124 (9): 838-42
56. Bodenheimer T. Primary care in the United States: innovations in primary care in the United States. BMJ 2003 Apr 12; 326 (7393): 796-8
57. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002 Oct 9; 288 (14): 1775-9
58. Academy of Managed Care Pharmacy. Principles of a sound drug formulary system [online]. Available from URL: http://www.amcp.org/publications/ index_publications.asp [Accessed 2003 May 3]
59. Joyce GF, Escarce JJ, Solomon DP, et al. Employer drug benefit plans and spending on prescription drugs. JAMA 2002 Oct 9; 288 (14): 1733-9
60. Carroll NV. How effectively do managed care organizations influence prescribing and dispensing decisions? Am J Manag Care 2002 Dec; 8 (12): 1041-54
61. Nair KV, Ganther JM, McCollynm MM, et al. Impact of multi-tiered pharmacy benefits on attitudes of plan members with chronic disease states. J Manag Care Pharm 2002 Nov/Dec; 8 (6): 477-91
62. Motheral B, Fairman KA. Effect of three-tier prescription copay on pharmaceutical and other medical utilization. Med Care 2001 Dec; 39 (12): 1293-304
63. Balas E, Boren S, Brown GD, et al. Effect of physician profiling on utilization: meta-analysis of randomized clinical trials. J Gen Intern Med 1996 Oct; 10 (11): 584-90
64. Levine S, Campen D, Millarees M, et al. Kaiser Permanente's prescription drug benefit. Health Aff 2000 Mar-Apr; 19 (2): 185-90
65. Glasgow RE, Funnell MM, Bonomi AE. Self-management aspects of the improving the chronic illness care breakthrough series: implementation with diabetes and heart failure teams. Ann Behav Med 2002 Spring; 24 (2): 80-7
66. Bodenheimer T, Lorig K, Holman H, et al. Patient self-management of chronic diseases in primary care. JAMA 2002 Nov 20; 288 (19): 2469-75
67. Candy PC. Preventing "information overdose": developing information-literate practitioners. J Contin Educ Health Prof 2000 Fall; 20 (4): 228-37
68. Tierney W. Improving clinical decisions and outcomes with information: a review. Int J Med Inf 2001 Jun; 62 (1): 1-9
69. Haynes RB, Hayward R, Lomas J. Bridges between health care research evidence and clinical practice. J Am Med Inform Assoc 1995 Nov-Dec; 2 (6): 342-50
70. O'Connor PJ, Amundson G, Christianson J. Performance failure of an evidence-based upper respiratory infection clinical guideline. J Fam Pract 1999 Sep; 48 (9): 690-7
71. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow practice guidelines? A framework for improvement. JAMA 1999 Oct; 282 (15): 1458-65
72. Soumerai SB, McLaughlin TJ, Gurwitz JH, et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA 1998 May; 279 (17): 1358-63
73. Davis D, Thomson M, Oxman AD, et al. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995 Sep 6; 274 (9): 700-5
74. Van Eijk M, Avorn J, Porsius AJ, et al. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 2001 Mar 17; (322): 1-5
75. Headrick LA, Speroff T, Pelecanos HI, et al. Efforts to improve compliance with the national cholesterol education program guidelines: results of a randomized controlled trial. Arch Intern Med 1992 Dec; 152 (12): 2490-6
76. Browner WS, Baron RB, Solkowitz S, et al. Physician management of hypercholesterolemia: a randomized trial of continuing medical education. West J Med 1994 Dec; 161 (6): 572-8
77. Hagen N, Young J, MacDonald N. Diffusion of standards of care for cancer pain. CMAJ 1995 Apr; 152 (8): 1205-9
78. Bach PB, Brown C, Gelfand SE, et al. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001; 134: 600-20
79. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy and pervention. Am J Respir Crit Care Med 2001; 163: 1730-54
80. Sinus and Allergy Health Partnership. Antimicrobial guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2000; 123: 5-31
81. Bisno AL, Gerber MA, Gwaltney Jr JM, et al. Practice guidelines for the diagnosis and management of Group A streptococcal pharyngitis: Infectious Diseases Society of America. Clin Infect Dis 2002; 35: 113-25
82. Hanlon J, Weinberger M, Samsa G, et al. A randomized, controlled trial of a clinical pharmacist's intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996 Apr; 100 (4): 428-37
83. Borgsdorf L, Miano J, Knapp K. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994 Mar 15; 51 (6): 772-7
84. Devoe J, Phil M, Fryer G, et al. Does career dissatisfaction affect the ability of family physicians to deliver high-quality patient care? J Fam Pract 2002 Mar; 51 (3): 223-8
85. Shortell S, Waters T, Clarke K, et al. Physicians as double agents: maintaining trust in an era of multiple accountabilities. JAMA Sep 23/30; 280 (12): 1102-8
86. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001 Nov 28; 286 (20): 2578-85
87. Holmes-Rovner M, Valade D, Orlowski C, et al. Implementing shared decision-making in routine practice: barriers and opportunities. Health Expect 2000 Sep; 3 (3): 182-91
88. Baines D, Whynes D, Tolley K. General practitioner fundholding and prescribing expenditure control, evidence from a rural english health authority. Pharmacoeconomics 1997 Apr; 11 (4): 350-8
89. McGavock H. Strategies to improve the cost effectiveness of general practitioner prescribing: an international perspective. Pharmacoeconomics 1997 Sep; 12 (3): 307-11
90. Milstein C, Venot A. Cost-related information to be provided by computerised drug-prescription systems to promote cost-effective prescribing. Pharmacoeconomics 1997 Aug 12; 2 (Pt 1): 130-9
91. Bloor K, Freemantle N. Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors. BMJ 1996 Jun 15; 312 (7045): 1525-7
92. De Vault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 1999; 94 (6): 1434-42
93. Bates DW, Teich J, Lee D, et al. The impact of computerized physician order on medication error prevention. J Am Med Inform Assoc 1999; 6 (4): 313-21
94. Ponedal S, Tucker M. Understanding decision support systems. J Managed Care Pharm 2002 Mar-Apr; 8 (2): 96-101
95. Monane M, Matthias D, Nagle B, et al. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA 1998 Oct 14; 280 (14): 1249-52
96. Bieszk N, Patel R, Heaberlin A, et al. Detection of mediation nonadherence through review of pharmacy claims data. Am J Health Syst Pharm 2003 Feb 15; 60 (4): 360-6
97. Bieszk N, Bhargava V, Petitta T, et al. Quality and cost outcomes of a clinical pharmacist intervention in a capitated senior drug benefit plan. J Managed Care Pharm 2002 Mar-Apr; 8 (2): 124-31
98. Armour BS, Pitts MM, MacLean R, et al. The effect of explicit financial incentives on physician behavior. Arch Intern Med 2001 May 28; 161 (10): 1261-6
99. McCombs JS, Liu G, Shi J, et al. The Kaiser Permanente/USC patient consultation study: change in use and cost of health care services. Am J Health Syst Pharm 1998 Dec 1; 55 (23): 2485-99
100. Gerber RA, Liu G, McCombs JS. Impact of pharmacist consultations provided to patients with diabetes on healthcare costs in a health maintenance organization. Am J Manag Care 1998 Jul; 4 (7): 991-1000
101. Ellis SL, Billups SJ, Malone DC, et al. Types of interventions made by clinical pharmacists in the IMPROVE study: impact of managed pharmaceutical care on resource utilization and outcomes in veteran's affairs medical centers. Pharmacotherapy 2000 Apr; 20 (4): 429-35
102. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in geriatric ambulatory clinics. Pharmacotherapy 2000 Oct; 20 (10): 1198-203
103. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE Study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veteran's Affairs Medical Centers. Pharmacotherapy 2000 Dec; 20 (12): 1508-16
104. Soumerai SB. Adding value to appropriate drug use and prescription drug programs: presented at the Appropriate Drug Use and Prescription Drug Programs: adding value by improving quality. Workshop brief, 2001, Nov 5-7, Association for Health Research and Outcomes (AHRQ), User Liaison Program [online]. Available from URL: http://www.ahrq.gov/news/ulp/pharm/pharm8.htm [Accessed 2003 Oct 14]